Covered recipient · General Payments record
DANIEL ISSER GOLDMAN
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$1,209.77
- Reported across 47 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $434.69 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $306.34 | 12 |
| Astellas Pharma US Inc | $77.67 | 3 |
| Biogen, Inc. | $28.48 | 1 |
| Bausch & Lomb Americas Inc. | $22.20 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $27.51 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811594 | CMS |
| ABBVIE INC. | $12.50 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811596 | CMS |
| ABBVIE INC. | $26.04 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811598 | CMS |
| ABBVIE INC. | $24.16 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811600 | CMS |
| ABBVIE INC. | $31.53 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811602 | CMS |
| ABBVIE INC. | $28.29 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811604 | CMS |
| ABBVIE INC. | $12.72 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811606 | CMS |
| ABBVIE INC. | $21.44 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811608 | CMS |
| ABBVIE INC. | $31.70 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811610 | CMS |
| ABBVIE INC. | $31.43 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811612 | CMS |
| ABBVIE INC. | $27.50 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811614 | CMS |
| ABBVIE INC. | $31.52 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811616 | CMS |
| Astellas Pharma US Inc | $14.28 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139304858 | CMS |
| Astellas Pharma US Inc | $32.68 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139332994 | CMS |
| Astellas Pharma US Inc | $30.71 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139432174 | CMS |
| Bausch & Lomb Americas Inc. | $22.20 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140328855 | CMS |
| Biogen, Inc. | $28.48 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104848952 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.